Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage.
Kimmelstiel C, Badar J, Covic L, Waxman S, Weintraub A, Jacques S, Kuliopulos A. Kimmelstiel C, et al. Among authors: weintraub a. Thromb Res. 2005;116(1):55-66. doi: 10.1016/j.thromres.2004.11.011. Epub 2004 Dec 8. Thromb Res. 2005. PMID: 15850609 Clinical Trial.
[Alcohol septal ablation and hypertrophic cardiomyopathy].
Kimmelstiel C, Krishnamurthy B, Weintraub A, Kapur N. Kimmelstiel C, et al. Among authors: weintraub a. Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Dec;37(12):1074-7. Zhonghua Xin Xue Guan Bing Za Zhi. 2009. PMID: 20193175 Chinese.
Elevated soluble fms-like tyrosine kinase-1 levels in acute coronary occlusion.
Kapur NK, Heffernan KS, Yunis AA, Nguyen TA, Aronovitz MJ, Parpos P, Wilson S, Baker CK, Esposito ML, Shah A, Kimmelstiel CD, Weintraub A, Karas RH, Mendelsohn ME. Kapur NK, et al. Among authors: weintraub a. Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):443-50. doi: 10.1161/ATVBAHA.110.215897. Epub 2010 Nov 11. Arterioscler Thromb Vasc Biol. 2011. PMID: 21071694
Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention.
Kimmelstiel C, Zhang P, Kapur NK, Weintraub A, Krishnamurthy B, Castaneda V, Covic L, Kuliopulos A. Kimmelstiel C, et al. Among authors: weintraub a. Circ Cardiovasc Interv. 2011 Apr 1;4(2):171-9. doi: 10.1161/CIRCINTERVENTIONS.110.959098. Epub 2011 Mar 1. Circ Cardiovasc Interv. 2011. PMID: 21364148 Free PMC article.
Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital Database.
Kimmelstiel C, Pinto D, Aronow HD, Weintraub AR, Dangas G, Fan W, Prats J, Deliargyris EN, Katzen BT. Kimmelstiel C, et al. Circ Cardiovasc Interv. 2016 Jan;9(1):e002823. doi: 10.1161/CIRCINTERVENTIONS.115.002823. Circ Cardiovasc Interv. 2016. PMID: 26747849
657 results